Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05487235
Title	A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
Recruitment	Recruiting
Gender	both
Phase	Phase I
Variant Requirements	Yes
Sponsors	Genentech, Inc.
Indications	head and neck squamous cell carcinoma lung non-small cell carcinoma melanoma Advanced Solid Tumor
Therapies	Atezolizumab + GDC-1971 Atezolizumab + GDC-1971 + Omeprazole
Age Groups:	senior \| adult
Covered Countries	USA \| NZL \| ESP \| CAN \| AUS